October 01, 2016 4:35 AM ET

Biotechnology

Company Overview of InteKrin Therapeutics Inc.

Company Overview

InteKrin Therapeutics Inc., a biopharmaceutical company, develops and commercializes therapeutics for inflammatory and metabolic disorders. The company offers INT131, a peroxisome proliferator-activated receptor gamma modulator that targets inflammation and activates neuroprotective pathways. The company was founded in 2005 and is based in Redwood City, California. As of February 12, 2014, InteKrin Therapeutics Inc. operates as a subsidiary of Coherus Biosciences, Inc.

201 Redwood Shores Parkway

Suite 200

Redwood City, CA 94065

United States

Founded in 2005

Phone:

650-941-5501

Fax:

866-491-7350

Key Executives for InteKrin Therapeutics Inc.

Founder, Chairman and Acting President
Age: 61
Chief Scientific Officer and Chief Medical Officer
Director of Russia Development
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact InteKrin Therapeutics Inc., please visit www.intekrin.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.